Caxton Associates (UK)’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Sell
261,354
-164,763
-39% -$1.84M 0.05% 221
2026
Q1
$4.61M Buy
426,117
+385,215
+942% +$3.3M 0.1% 76
2025
Q4
$250K Buy
+40,902
New +$244K ﹤0.01% 658

Other funds holding PTEN

Caxton Associates (UK)'s PTEN Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Patterson-UTI (PTEN) stake by 39% in Q2 2026, selling an estimated $1.84M and leaving 261,354 shares worth $2.4M. The position accounts for 0.05% of the portfolio, ranked #221.

Caxton Associates (UK) first reported a position in PTEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.61M in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Caxton Associates (UK) held 261,354 shares of Patterson-UTI worth $2.4M as of Q2 2026.
  • Caxton Associates (UK) sold 164,763 Patterson-UTI shares in Q2 2026, an estimated $1.84M.
  • Patterson-UTI made up 0.05% of Caxton Associates (UK)'s portfolio in Q2 2026, its #221 holding.
  • Caxton Associates (UK) first reported a position in Patterson-UTI in Q4 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Patterson-UTI position peaked at $4.61M in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.